Market open
STERIS /$STE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About STERIS
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Ticker
$STE
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
18,000
ISIN
IE00BFY8C754
Website
STERIS Metrics
BasicAdvanced
$23B
48.99
$4.72
0.84
$2.23
0.99%
Price and volume
Market cap
$23B
Beta
0.84
52-week high
$245.06
52-week low
$200.98
Average daily volume
669K
Dividend rate
$2.23
Financial strength
Current ratio
2.13
Quick ratio
1.201
Long term debt to equity
31.714
Total debt to equity
33.658
Dividend payout ratio (TTM)
46.04%
Interest coverage (TTM)
9.11%
Management effectiveness
Return on assets (TTM)
5.65%
Return on equity (TTM)
9.61%
Valuation
Price to earnings (TTM)
48.989
Price to revenue (TTM)
4.227
Price to book
3.54
Price to tangible book (TTM)
49.35
Price to free cash flow (TTM)
30.368
Dividend yield (TTM)
0.96%
Forward dividend yield
0.99%
Growth
Revenue change (TTM)
12.92%
Earnings per share change (TTM)
-16.95%
3-year revenue growth (CAGR)
8.32%
3-year earnings per share growth (CAGR)
16.85%
3-year dividend per share growth (CAGR)
9.51%
What the Analysts think about STERIS
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for STERIS stock.
STERIS Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
STERIS Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
STERIS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market open
Upcoming events
Jun10
STERIS
Dividend·Ex-dividend
Jun26
STERIS
Dividend·Payment
$0.57Per share
FAQs
What’s the current market cap for STERIS stock?
STERIS (STE) has a market cap of $23B as of May 14, 2025.
What is the P/E ratio for STERIS stock?
The price to earnings (P/E) ratio for STERIS (STE) stock is 48.99 as of May 14, 2025.
Does STERIS stock pay dividends?
Yes, the STERIS (STE) stock pays dividends to shareholders. As of May 14, 2025, the dividend rate is $2.23 and the yield is 0.99%. STERIS has a payout ratio of 46.04% on a trailing twelve-month basis.
When is the next STERIS dividend payment date?
The next STERIS (STE) dividend payment is scheduled for June 26, 2025.
What is the beta indicator for STERIS ?
STERIS (STE) has a beta rating of 0.84. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.